Premium
Patient‐derived sarcoma xenografts for individual‐patient selection of chemotherapy—ready for prime time?
Author(s) -
Wagner Andrew J.
Publication year - 2014
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28694
Subject(s) - medicine , sarcoma , chemotherapy , selection (genetic algorithm) , oncology , pathology , artificial intelligence , computer science
Patient‐derived sarcoma tumor xenografts can be successfully grown in mice and tested for sensitivity to chemotherapy regimens. Are these tests ready to guide patient care?